Results 201 to 210 of about 24,552 (280)

BTK NP_000052.1:pC481X [PDF]

, 2020
openaire   +1 more source

A quantitative mechanistic PK/PD model directly connects Btk target engagement and in vivo efficacy

, 2017
Fereidoon Daryaee, Zhuo Zhang, Kayla R. Gogarty, Yong Li, Jonathan Merino, Stewart L. Fisher, Peter J. Tonge   +6 more
openalex   +2 more sources

Expression of Bruton's Tyrosine Kinase Reflects Immune Cells Infiltration and Cell Proliferation in Breast Cancer. [PDF]

World J Oncol
AlRammah T, Wu R, Chida K, Kawashima K, Hakamada K, Ishikawa T, Ebos JML, Takabe K.   +7 more
europepmc   +1 more source

Data from First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma

Jennifer A. Woyach, Deborah M. Stephens, Ian W. Flinn, Seema A. Bhat, Ronald E. Savage, Feng Chai, Sudharshan Eathiraj, Sean D. Reiff, Elizabeth M. Muhowski, Lindsey Granlund, Lyndsey Szuszkiewicz, Wayne Wang, Brian Schwartz, Razi Ghori, Mohammed Z.H. Farooqui, John C. Byrd   +15 more
openalex   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Common biomarkers of Alzheimer disease and postoperative delirium. [PDF]

Medicine (Baltimore)
Fang Y, Zhang X, Zhan G.
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Molecular Insights and Novel Therapies for Lymphoproliferative Disorders. [PDF]

Int J Mol Sci
Wan S, Naik S.
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral-BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens. [PDF]

Pharmaceutics
Chen L, Wang X, Li L, Yang Y, Liu Y, Chen W.   +5 more
europepmc   +1 more source